88.37
1.41 (1.62%)
Previous Close | 86.96 |
Open | 85.00 |
Volume | 909,581 |
Avg. Volume (3M) | 979,803 |
Market Cap | 7,643,686,912 |
Price / Earnings (TTM) | 81.07 |
Price / Earnings (Forward) | 24.75 |
Price / Sales | 6.69 |
Price / Book | 3.69 |
52 Weeks Range | |
Earnings Date | 2 Jun 2025 - 6 Jun 2025 |
Profit Margin | 8.06% |
Operating Margin (TTM) | 14.22% |
Diluted EPS (TTM) | 1.09 |
Quarterly Revenue Growth (YOY) | 18.80% |
Total Debt/Equity (MRQ) | 52.42% |
Current Ratio (MRQ) | 3.06 |
Operating Cash Flow (TTM) | 339.86 M |
Levered Free Cash Flow (TTM) | -145.32 M |
Return on Assets (TTM) | 3.84% |
Return on Equity (TTM) | 4.66% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Mixed | Mixed |
Health Information Services (Global) | Mixed | Mixed | |
Stock | HealthEquity, Inc. | Bearish | Bullish |
AIStockmoo Score
Analyst Consensus | 2.0 |
Insider Activity | NA |
Price Volatility | 2.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -0.5 |
Average | 1.50 |
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
% Held by Insiders | 2.14% |
% Held by Institutions | 106.13% |
52 Weeks Range | ||
Price Target Range | ||
High | 125.00 (Wells Fargo, 41.45%) | Buy |
Median | 112.00 (26.74%) | |
Low | 94.00 (Goldman Sachs, 6.37%) | Hold |
Average | 111.20 (25.84%) | |
Total | 4 Buy, 1 Hold | |
Avg. Price @ Call | 91.85 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Goldman Sachs | 27 Mar 2025 | 94.00 (6.37%) | Hold | 88.83 |
Raymond James | 25 Mar 2025 | 115.00 (30.13%) | Buy | 90.19 |
25 Feb 2025 | 120.00 (35.79%) | Buy | 107.45 | |
Keybanc | 24 Mar 2025 | 110.00 (24.48%) | Buy | 90.32 |
Barrington Research | 19 Mar 2025 | 112.00 (26.74%) | Buy | 84.32 |
14 Mar 2025 | 112.00 (26.74%) | Buy | 97.41 | |
Wells Fargo | 26 Feb 2025 | 125.00 (41.45%) | Buy | 105.61 |
No data within this time range.
Date | Type | Details |
---|---|---|
18 Mar 2025 | Announcement | HealthEquity Assist™: A new suite of integrated benefit solutions that drive deeper engagement, deliver cost savings, and increase transparency for employee benefits |
18 Mar 2025 | Announcement | HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results |
11 Mar 2025 | Announcement | HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle |
27 Feb 2025 | Announcement | Forbes and U.S. News & World Report Agree: HealthEquity is One of America’s Best Places to Work |
20 Feb 2025 | Announcement | The Path Forward: How Commuting Impacts the Return to Office Experience |
18 Feb 2025 | Announcement | HealthEquity Reports Year-End Sales Metrics |
28 Jan 2025 | Announcement | Tech-Powered Innovation Transforms Member Experiences and Earns HealthEquity Industry Recognition |
13 Jan 2025 | Announcement | HealthEquity Announces Record Year-End HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |